Scholarlink

<p>Diabetes is a&#xa0;common secondary diagnosis in hospitalized patients and has a&#xa0;significant impact on the course of hospitalization and treatment outcomes. Diabetes management in the inpatient setting is complex and resource-intensive. To date, the involvement of specialized diabetes care teams in patients with diabetes as a&#xa0;secondary diagnosis remains insufficient. Insulin as the standard therapy for glucose control is highly effective but carries a&#xa0;substantial risk of fatal events in cases of dosing errors. In the outpatient setting, the use of continuous glucose monitoring (CGM) systems has fundamentally improved diabetes care—enhancing glucose control, safety, and quality of life, while reducing the necessity of hospitalization. Transferring this technological tool from the outpatient to the inpatient setting offers numerous advantages as compared to the current standard of point-of-care glucose testing. Integrating CGM into inpatient diabetes care requires overcoming multiple barriers, generating additional scientific evidence, and establishing new procedures and workflows in clinical care. Awareness of this technology’s potential for inpatient settings is steadily increasing and the integration process is progressing. In the hospital setting, CGM can represent more than the mere introduction of a&#xa0;new technology; rather it has the potential to serve as a&#xa0;starting point for a&#xa0;new quality of inpatient care—from automated in-hospital metabolite monitoring and improved diabetes management as a&#xa0;use case, to the support of clinical decision-making and trans-hospital telemedical care integration.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Perioperatives Management von Menschen mit Diabetes mellitus: CGM im Krankenhaus

  • 期刊论文

  • 发表日期：

    2026年2月17日

查看全文
  • Susanne Reger-Tan,
  • Young Hee Lee-Barkey,
  • Bernd Stratmann,
  • Jasmin M. Klose,
  • Lutz Heinemann

摘要

Diabetes is a common secondary diagnosis in hospitalized patients and has a significant impact on the course of hospitalization and treatment outcomes. Diabetes management in the inpatient setting is complex and resource-intensive. To date, the involvement of specialized diabetes care teams in patients with diabetes as a secondary diagnosis remains insufficient. Insulin as the standard therapy for glucose control is highly effective but carries a substantial risk of fatal events in cases of dosing errors. In the outpatient setting, the use of continuous glucose monitoring (CGM) systems has fundamentally improved diabetes care—enhancing glucose control, safety, and quality of life, while reducing the necessity of hospitalization. Transferring this technological tool from the outpatient to the inpatient setting offers numerous advantages as compared to the current standard of point-of-care glucose testing. Integrating CGM into inpatient diabetes care requires overcoming multiple barriers, generating additional scientific evidence, and establishing new procedures and workflows in clinical care. Awareness of this technology’s potential for inpatient settings is steadily increasing and the integration process is progressing. In the hospital setting, CGM can represent more than the mere introduction of a new technology; rather it has the potential to serve as a starting point for a new quality of inpatient care—from automated in-hospital metabolite monitoring and improved diabetes management as a use case, to the support of clinical decision-making and trans-hospital telemedical care integration.